[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![OpenOutcrier Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::2334614718.png) Open Outcrier [@OpenOutcrier](/creator/twitter/OpenOutcrier) on x 79.5K followers
Created: 2025-06-27 12:26:40 UTC

$BMY (+0.4% pre) U.S. Food and Drug Administration Approves Streamlined Patient Monitoring Requirements and Removal of REMS Programs within Bristol Myers Squibb’s Cell Therapy Labels




XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1938574701246235049/c:line.svg)

**Related Topics**
[$bmy](/topic/$bmy)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/OpenOutcrier/status/1938574701246235049)